More Info on CIRM's Finances and its Federal Patent Lobbying Position
The California stem cell agency today posted several major background information pieces for its board meeting, including details and justification for its proposed budget and an analysis dealing with its endorsement of industry-backed patent protection legislation.
The documents came as the agency is scheduled to begin a two-day meeting tomorrow in San …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.